Hundreds of British patients with heart failure are to get a chance to try new gene therapies, it was announced yesterday.
British researchers revealed plans to start testing a treatment on patients within the next few weeks – after 20 years of research.
They will test a therapy that aims to insert extra genes into heart cells aimed at producing the protein SERCA2a.
One trial will involve 200 patients and a second trial will test the treatment on 24 patients with mechanical heart pumps.
The project is centred on the Royal Brompton Hospital, London, Harefield Hospital and Imperial College London.
Cardiologist Dr Alexander Lyon said: “Our goal is to fight back against heart failure by targeting and reversing some of the critical molecular changes arising in the heart when it fails.”
Treatment developer Professor Sian Harding, of Imperial College, added: “It’s been a painstaking, 20-year process to find the right gene and make a treatment that works, but we’re thrilled to be working with cardiologists to set up human trials that could help people living with heart failure.
"It’s been a long journey to get to this point and we are proud to have helped to develop the first therapy under investigation in clinical trials for people with heart disease.”

Leave a Reply